Published in Nutrition on February 01, 1998
Arginine de novo and nitric oxide production in disease states. Am J Physiol Endocrinol Metab (2012) 1.06
Favorable effects of preoperative enteral immunonutrition on a surgical site infection in patients with colorectal cancer without malnutrition. Surg Today (2006) 0.95
Attenuation of the systemic inflammatory response and infectious complications after gastrectomy with preoperative oral arginine and omega-3 fatty acids supplemented immunonutrition. World J Surg (2009) 0.94
Immunonutrition before and during radiochemotherapy: improvement of inflammatory parameters in head and neck cancer patients. Support Care Cancer (2012) 0.83
Clinical significance of perioperative immunonutrition for patients with esophageal cancer. World J Surg (2007) 0.82
Nutritional Care of Gastric Cancer Patients with Clinical Outcomes and Complications: A Review. Clin Nutr Res (2016) 0.80
Fish oil in critical illness: mechanisms and clinical applications. Crit Care Clin (2010) 0.77
Immunonutrition - the influence of early postoperative glutamine supplementation in enteral/parenteral nutrition on immune response, wound healing and length of hospital stay in multiple trauma patients and patients after extensive surgery. GMS Interdiscip Plast Reconstr Surg DGPW (2015) 0.75
Hemorrhagic Shock and Tissue Injury Drive Distinct Plasma Metabolome Derangements in Swine. J Trauma Acute Care Surg (2017) 0.75
Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med (2001) 7.71
Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg (1991) 3.12
Care of the polytraumatised patient. J Bone Joint Surg Br (1996) 2.69
Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg (1996) 2.54
Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study. Lancet (2001) 2.39
Regulation of gastric epithelial cell growth by Helicobacter pylori: offdence for a major role of apoptosis. Gastroenterology (1997) 2.39
A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation--PROTECT. Am J Transplant (2012) 2.24
Hereditary hemorrhagic telangiectasia: effective protocol for embolization of hepatic vascular malformations--experience in five patients. Radiology (1998) 2.12
Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D. Lancet (1994) 2.05
Endoscopic ultrasound as an early diagnostic tool for primary sclerosing cholangitis: a prospective pilot study. Endoscopy (2012) 2.01
Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol (2000) 2.00
Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C. Gut (2001) 1.97
Mechanisms of hepatic toxicity. I. TNF-induced liver injury. Am J Physiol (1998) 1.89
Benign liver tumors: differential diagnosis and indications for surgery. World J Surg (1997) 1.83
Association between fulminant hepatic failure and a strain of GBV virus C. Lancet (1996) 1.82
Surgical options for the treatment of severe tibial pilon fractures: a study of three techniques. J Orthop Trauma (2001) 1.82
Late results of thoracolumbar fractures after posterior instrumentation and transpedicular bone grafting. Spine (Phila Pa 1976) (2001) 1.75
Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Endoscopy (2006) 1.70
Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass. Development (1999) 1.69
The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release. Mol Cell Biol (1998) 1.66
Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis. Gut (2008) 1.65
Pattern of organ failure following severe trauma. World J Surg (1996) 1.63
CREB controls LAP/C/EBP beta transcription. Mol Cell Biol (1997) 1.62
Analysis of factors contributing to higher erythropoietin levels in patients with chronic liver disease. Scand J Gastroenterol (2004) 1.60
Primary intramedullary femur fixation in multiple trauma patients with associated lung contusion--a cause of posttraumatic ARDS? J Trauma (1993) 1.56
Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology (1996) 1.53
Auxiliary partial orthotopic liver transplantation for acute liver failure in two children. Pediatr Transplant (1999) 1.51
Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Front Immunol (2012) 1.50
Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate. Transpl Immunol (2008) 1.49
Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology (2000) 1.49
Surgical treatment of cholangiocellular carcinoma. World J Surg (1995) 1.47
Value of magnifying chromoendoscopy and narrow band imaging (NBI) in classifying colorectal polyps: a prospective controlled study. Endoscopy (2007) 1.46
Targeted adenovirus mediated inhibition of NF-κB-dependent inflammatory gene expression in endothelial cells in vitro and in vivo. J Control Release (2012) 1.45
Structural organization of the hepatitis B virus minichromosome. J Mol Biol (2001) 1.45
Endoscopic management of biliary tract strictures in primary sclerosing cholangitis. Endoscopy (1996) 1.44
Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseases. Proc Natl Acad Sci U S A (2000) 1.44
Treatment results of patients with multiple trauma: an analysis of 3406 cases treated between 1972 and 1991 at a German Level I Trauma Center. J Trauma (1995) 1.42
Intestinal cytokine response after gut ischemia: role of gut barrier failure. Ann Surg (1999) 1.42
[Compound osteosynthesis as treatment for an osteoporotic LWK-1 burst fracture in a 76 year old female patient]. Unfallchirurg (2005) 1.38
Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol (1999) 1.38
NFkappaB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitis. J Biol Chem (2000) 1.37
[Inter-observer reliability in the classification of thoraco-lumbar spinal injuries]. Orthopade (1999) 1.37
The functional relevance of passenger leukocytes and microchimerism for heart allograft acceptance in the rat. Nat Med (1999) 1.35
Evaluation of the mobility of adjacent segments after posterior thoracolumbar fixation: a biomechanical study. Eur Spine J (2001) 1.34
Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake. Gut (2005) 1.34
[Development and validation of the Visual Analogue Scale (VAS) Spine Score]. Unfallchirurg (2001) 1.34
Interleukin 6 and liver regeneration. Gut (2000) 1.32
Evaluation of cervical cytology. Evid Rep Technol Assess (Summ) (1999) 1.30
GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients? J Infect Dis (1998) 1.27
Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis. Hepatology (1996) 1.27
[Fractures of the thoracolumbar spine. Late results of dorsal instrumentation and its consequences]. Unfallchirurg (1997) 1.26
Stimulation of collagen alpha 1(I) gene expression is associated with lipid peroxidation in hepatocellular injury: a link to tissue fibrosis? Hepatology (1994) 1.26
Performance evaluation of the ADVIA 2120 hematology analyzer: an international multicenter clinical trial. Lab Hematol (2005) 1.25
Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology (1997) 1.24
Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value. J Hepatol (1997) 1.24
Hyperstimulation with interleukin 6 inhibits cell cycle progression after hepatectomy in mice. Hepatology (2000) 1.24
Interleukin-6-induced tethering of STAT3 to the LAP/C/EBPbeta promoter suggests a new mechanism of transcriptional regulation by STAT3. J Biol Chem (2000) 1.23
Free radicals may contribute to oxidative skeletal muscle fatigue. Can J Physiol Pharmacol (1991) 1.22
Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology (1997) 1.21
Hepatocellular hyperplasia, plasmacytoma formation, and extramedullary hematopoiesis in interleukin (IL)-6/soluble IL-6 receptor double-transgenic mice. Am J Pathol (1998) 1.19
In vitro susceptibilities of wild-type or drug-resistant hepatitis B virus to (-)-beta-D-2,6-diaminopurine dioxolane and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil. Antimicrob Agents Chemother (2001) 1.18
Interaction of human phagocytes with pigmentless Aspergillus conidia. Infect Immun (2000) 1.18
NF-kappaB determines between apoptosis and proliferation in hepatocytes during liver regeneration. Am J Physiol Gastrointest Liver Physiol (2000) 1.18
Results of hepatic resection and transplantation for fibrolamellar carcinoma. Surg Gynecol Obstet (1992) 1.17
Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit? J Hepatol (1998) 1.17
Trauma care in Germany. Injury (2003) 1.16
Long-term experience after ex situ liver surgery. Surgery (2000) 1.16
Complications in surgical treatment of thoracolumbar injuries. Eur Spine J (2002) 1.13
TNF-alpha-induced expression of adhesion molecules in the liver is under the control of TNFR1--relevance for concanavalin A-induced hepatitis. J Immunol (2001) 1.13
Donor-type microchimerism associated with graft rejection eight years after liver transplantation. N Engl J Med (1994) 1.13
A preS mutation isolated from a patient with chronic hepatitis B infection leads to virus retention and misassembly. Gastroenterology (1997) 1.13
Mediators of inflammation and acute phase response in the liver. Cell Mol Biol (Noisy-le-grand) (2001) 1.10
Cross-resistance testing of antihepadnaviral compounds using novel recombinant baculoviruses which encode drug-resistant strains of hepatitis B virus. Antimicrob Agents Chemother (2001) 1.09
Liver transplantation for metastatic neuroendocrine tumors. Ann Surg (1997) 1.09
Perioperative morbidity and quality of life in long-term survivors following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol (2005) 1.09
Development, stability, and clinical correlations of allogeneic microchimerism after solid organ transplantation. Transplantation (1996) 1.08
[Magnetic resonance tomography in therapy follow-up after repositioning treatment of congenital hip dislocation]. Z Orthop Ihre Grenzgeb (1998) 1.08
Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma. Br J Surg (2000) 1.06
Three-dimensional motion analysis with Synex. Comparative biomechanical test series with a new vertebral body replacement for the thoracolumbar spine. Eur Spine J (2000) 1.06
Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure. Am J Pathol (1999) 1.06
IFN-mediated induction of MHC antigen expression on human keratinocytes and its influence on in vitro alloimmune responses. J Immunol (1988) 1.06
The interleukin-6 (IL6)-174 G/C promoter genotype is associated with the presence of septic shock and the ex vivo secretion of IL6. Int J Immunogenet (2007) 1.06
Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma. Cancer Res (1997) 1.05
Fate of the transpedicular intervertebral bone graft after posterior stabilisation of thoracolumbar fractures. Eur Spine J (2002) 1.05
Validation of connective tissue growth factor (CTGF/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosis. J Viral Hepat (2009) 1.05
Mesenchymal stem cells together with mycophenolate mofetil inhibit antigen presenting cell and T cell infiltration into allogeneic heart grafts. Transpl Immunol (2010) 1.04
Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation. Hepatology (1999) 1.04
Blunt abdominal trauma in cases of multiple trauma evaluated by ultrasonography: a prospective analysis of 291 patients. J Trauma (1992) 1.04
Internal fixation of multiple fractures in patients with polytrauma. Clin Orthop Relat Res (1998) 1.01
Severe hepatic injury in interleukin 18 (IL-18) transgenic mice: a key role for IL-18 in regulating hepatocyte apoptosis in vivo. Gut (2004) 1.01
Cancer cell invasion and EMT marker expression: a three-dimensional study of the human cancer-host interface. J Pathol (2014) 1.01
Computer-aided classification of colorectal polyps based on vascular patterns: a pilot study. Endoscopy (2010) 1.01
Isolation, culture, and characterization of human pancreatic duct cells. Pancreas (1993) 1.00
Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei. Int J Colorectal Dis (2004) 1.00
The designer cytokine hyper-interleukin-6 is a potent activator of STAT3-dependent gene transcription in vivo and in vitro. J Biol Chem (1999) 1.00
Disease will limit future food supply from the global crustacean fishery and aquaculture sectors. J Invertebr Pathol (2012) 0.99